SciSparc Advances SCI-210 Clinical Trial for Autism Symptoms as Enrollment Reaches 26 Children

SciSparc Ltd. (“Company” or “SciSparc”), announced that NeuroThera Labs Inc.  ("NeuroThera"), a clinical-stage pharmaceuti...

September 02, 2026 | Wednesday | News
NexLife Expands Compounded GLP-1 Program With Four Protocols Under Flat-Rate Pricing Model

NexLife, a LegitScript-certified, physician-led telehealth platform, announced that its compounded GLP-1 program now spans four protocols under a single ...

September 02, 2026 | Wednesday | News
Arrowhead Pharmaceuticals’ Plozasiran Cuts Triglycerides by Up to 81% in Phase 3 SHASTA Trials

- Plozasiran reduced triglycerides (TG) by 79% and 81% versus placebo in SHASTA-3 and SHASTA-4 across the broad sHTG population - - More than 90% of p...

September 01, 2026 | Tuesday | News
Leios Therapeutics Grants CMS Exclusive China Rights to 10XB-101 for Focal Fat Reduction

10XB-101 is a Novel Potential Best-in-Class Injectable Drug Being Developed for Focal Fat Reduction and Body Contouring  Second Major Regional Lice...

September 01, 2026 | Tuesday | News
Teva Bids to Acquire BioXcel’s Novel At-Home Neuroscience Treatment for Agitation

Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. announced it has made a bid to acquire an innovative neurosc...

August 31, 2026 | Monday | News
Revolution Medicines Wins FDA Approval for RASONQUE in Metastatic Pancreatic Cancer

Revolution Medicines, Inc., a global commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patie...

August 28, 2026 | Friday | News
Immuneering Advances Atebimetinib Phase 3 Trial in First-Line Metastatic Pancreatic Cancer

Immuneering Corporation, a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, shared comments followi...

August 28, 2026 | Friday | News
Thermo Fisher Scientific Launches Orbitrap Isora Mass Spectrometers for Molecular-Level Isotope Analysis

Thermo Fisher Scientific, the world leader in serving science, introduced the Thermo Scientific Orbitrap Isora Mass Spectrometer and Orbitrap Isora Pro M...

August 27, 2026 | Thursday | News
Vector Science and Therapeutics Enters Investor Relations Agreement With RedChip

Vector Science and Therapeutics Corp. ("Vector" or the "Company") is pleased to announce that the Company has entered into an investo...

August 27, 2026 | Thursday | News
Caliway Advances CBL-514 With U.S. FDA Clearance and Phase 3 Trial Launch

Caliway Biopharmaceuticals, a clinical-stage biopharmaceutical company developing innovative small-molecule therapeutics, announced two major clinical mi...

August 27, 2026 | Thursday | News
NeuroThera and Clearmind Advance MDMA-PEA Program With U.S. Patent Application Publication

SciSparc Ltd.(“Company” or “SciSparc”), announced that its  subsidiary, NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a ...

August 26, 2026 | Wednesday | News
Leads Biolabs Advances Opamtistomig into Expansion Phase in First-Line Esophageal Cancer Trial

Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,”  announced that Opamtistomig (LBL-024), the Company&rsquo...

August 26, 2026 | Wednesday | News
Johnson & Johnson Wins EU Approval for TECVAYLI Plus Daratumumab in Earlier-Line Multiple Myeloma

Johnson & Johnson announced that the European Commission (EC) has approved an indication extension for TECVAYLI®(teclistamab) in combination with...

August 24, 2026 | Monday | News
Orum Therapeutics Wins FDA Clearance for ORM-1153 AML Degrader-Antibody Conjugate

Orum Therapeutics(“Orum” or the “Company”), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), ...

August 24, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close